Form 4 filings across 1 company. Net figures count open-market buys and sales only. EDGAR profile ↗
Lifetime net: $0
Reported holding is the most recent post-transaction share count on a Table I row.
How quickly this filer reports. Section 16 allows two business days from the transaction.
All 8 filings we hold were filed within the two-business-day deadline.
Counted in business days from the transaction date, or the deemed execution date where the filing reports one, excluding weekends and federal holidays. How this is measured · All late filings
The 11 most recent Form 4 transactions.
| Sep 23 | TBPH | Theravance Biopharma, Inc. | DTOISS | 93,108 | — | — | -49.0% | Open the original filing on SEC.gov |
| Aug 20 | TBPH | Theravance Biopharma, Inc. | FTAX | 6,258 | $16.95 | $106.1K | -3.2% | Open the original filing on SEC.gov |
| Jun 19 | TBPH | Theravance Biopharma, Inc. | AGRANT | 18,750 | — | — | +10.6% | Open the original filing on SEC.gov |
| May 20 | TBPH | Theravance Biopharma, Inc. | FTAX | 6,827 | $16.55 | $113K | -3.7% | Open the original filing on SEC.gov |
| Feb 20 | TBPH | Theravance Biopharma, Inc. | FTAX | 16,851 | $19.66 | $331.3K | -8.4% | Open the original filing on SEC.gov |
| Nov 20, 2025 | TBPH | Theravance Biopharma, Inc. | FTAX | 6,989 | $17.90 | $125.1K | -3.4% | Open the original filing on SEC.gov |
| Aug 20, 2025 | TBPH | Theravance Biopharma, Inc. | FTAX | 6,989 | $13.39 | $93.6K | -3.3% | Open the original filing on SEC.gov |
| May 20, 2025 | TBPH | Theravance Biopharma, Inc. | FTAX | 9,701 | $9.45 | $91.7K | -4.3% | Open the original filing on SEC.gov |
| May 19, 2025 | TBPH | Theravance Biopharma, Inc. | AGRANT | 10,430 | — | — | +4.9% | Open the original filing on SEC.gov |